629 results about "Shunting" patented technology

Sutureless, implantable fluid shunting devices and associated methods for controlling the pressure of fluids within anatomical spaces or cavities of the body. The device generally comprises a tube having a diffusion barrier (e.g., diffusion chamber) formed on a proximal end thereof. Fluid which flows through the tube will collect within the diffusion chamber and will diffuse outwardly therethrough. However, the presence of the diffusion chamber will prevent microbes, cells or other matter from interfering with or backflowing through the tube. Additionally, the tube may be provided with a pressure-openable aperture through which fluid from the tube may flow into the diffusion chamber. Such pressure-openable aperture will remain closed, until the pressure of fluid within the tube exceeds a predetermined maximum pressure PMAX. In this manner, the pressure-openable aperture will limit the amount of fluid drained from the anatomical space or cavity of the body, thereby avoiding hypotony within such anatomical space or cavity. The diffusion barrier of the device is preferably configured to fit between, and to be engaged by, adjacent recti muscles of the eye. Such engagement of the diffusion barrier with the adjacent recti muscles serves to prevent unwanted migration or post-implantation movement of the device, without the need for suturing of the device to the tissue of the eye.

Methods and apparatus for decreasing cardiac pressure in a patient by implanting a shunt communicating with an area outside a first portion, whereby a volume of blood sufficient to reduce pressure in a first portion is released. Preferably, the end diastolic pressure in the left ventricle is reduced, which is accomplished by having the shunt communicate with the left ventricle so a small volume of blood is released from the left ventricle. Most preferably, the shunt selectively permits flow when a pressure differential between the left ventricle and another chamber of a heart above a threshold pressure, so that shunting is prevented during left ventricular systole, or, alternatively, selectively permits flow when a pressure differential between the left ventricle and another chamber of a heart is between a lower threshold and a higher threshold. In certain embodiments a semi-passive check-valve is controlled and actuated by an external signal.

An anti-siphon device limits the flow of a fluid from a first region of a patient's body to a second region. The device includes a housing having a spherical inner surface with a predetermined inner diameter. The housing has an inlet port for receiving fluid from the first region and an outlet port for directing fluid to the second region. The inlet port and the outlet port are disposed approximately diametrically opposite from each other. A spherical ball is disposed within the housing. The spherical ball has a ferromagnetic weight disposed off center therein. The spherical ball has an outer diameter that is less than the inner diameter of the housing so that the spherical ball is free to rotate within the housing and the fluid is free to flow between the inner surface of the housing and an outer surface of said spherical ball. The spherical ball has a circumferential recess extending through its center.

An MRAM structure is disclosed in which the bottom electrode has an amorphous TaN capping layer to consistently provide smooth and dense growth for AFM, pinned, tunnel barrier, and free layers in an overlying MTJ. Unlike a conventional Ta capping layer, TaN is oxidation resistant and has high resistivity to avoid shunting of a sense current caused by redeposition of the capping layer on the sidewalls of the tunnel barrier layer. Alternatively, the α-TaN layer is the seed layer in the MTJ. Furthermore, the seed layer may be a composite layer comprised of a NiCr, NiFe, or NiFeCr layer on the α-TaN layer. An α-TaN capping layer or seed layer can also be used in a TMR read head. An MTJ formed on an α-TaN capping layer has a high MR ratio, high Vb, and a RA similar to results obtained from MTJs based on an optimized Ta capping layer.

Some embodiments of the invention relate to an inhaler device for pulmonary delivery of at least one substance from a drug dose cartridge to an inhaling user, comprising: a first conduit for conducting a carrier airflow to a proximal opening of a mouthpiece for use by the user; a holder configured to position the dose cartridge within the carrier airflow; and a second conduit for conducting a shunting airflow to the mouthpiece without passing through the dose cartridge position. In some embodiments, a controller connected to a valve controls a rate of carrier airflow, for example by controlling the shunting airflow, based on a sensor indication of airflow rate and a target airflow profile.

Some embodiments of the invention relate to an inhaler device for pulmonary delivery of at least one substance from a drug dose cartridge to an inhaling user, comprising: a first conduit for conducting a carrier airflow to a proximal opening of a mouthpiece for use by the user; a holder configured to position the dose cartridge within the carrier airflow; and a second conduit for conducting a shunting airflow to the mouthpiece without passing through the dose cartridge position. In some embodiments, a controller connected to a valve controls a rate of carrier airflow, for example by controlling the shunting airflow, based on a sensor indication of airflow rate and a target airflow profile.

An electronic apparatus (1) for training an animal is supported against the animal's skin, and includes stimulus electrodes (5) for electrically contacting the skin. A controller including output terminals producing aversive stimulus control signals, a first switch (Q4) coupled to a winding to produce therein a burst of first current pulses in response to a first signal produced by the controller (33) and a second switch (Q2) coupled to the first switch (Q4) operative to synchronously shunt predetermined trailing portions of the first current pulses away from the winding in response to a second signal produced by the controller to reduce the amount of energy delivered to the winding by the switching transistor (Q4) without substantially changing a peak value of a flyback voltage across the winding. The controller sets various values of time intervals during which portions of the first current pulses are shunted away from the winding in order to set various corresponding intensities of aversive stimulus.

An elevator group supervisory control apparatus is obtained which can achieve efficient group supervisory control while preventing or reducing the possibility of collision and the safe stopping of an upper car and a lower car in one and the same shaft as much as possible. The apparatus includes a hall destination floor registration device 4 that is installed in each hall and has a destination floor registration function and a function of providing a predictive indication of a response car for each destination floor, a zone setting section 12 that sets priority zones and a common zone for each of upper and lower cars, an entry determination section 13 that determines whether the upper and lower cars can come into the common zone, a safe waiting section 14 that makes the cars 20 wait safely in accordance with the determination result of the entry determination section 13, a shunting section 15 that makes each car 20 move to a shunting floor as required at the instant when each car finished its service, a confinement time prediction section 16 that predicts a confinement time due to safe waiting when each car is assigned to a destination call generated in a hall, an evaluation value calculation section 17 that evaluates a waiting time, the confinement time, etc., upon assignment of each car, and an assignment section 18 that determines a final assigned car on the basis of the calculation result of the evaluation value calculation section 17.